ConductScience.org, home

Gene · 1573

CYP2J2: cytochrome P450 family 2 subfamily J member 2

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. CYP2J2: cytochrome P450 family 2 subfamily J member 2. Genes, record 1573. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1573

On this page

Gene

Symbol
CYP2J2
HGNC
Name
cytochrome P450 family 2 subfamily J member 2
HGNC
NCBI Gene ID
1573
NCBI Gene
HGNC ID
HGNC:2634
HGNC
Ensembl
ENSG00000134716
NCBI Gene
Aliases
CPJ2, CYPIIJ2
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P51589Cytochrome P450 2J25020Ensembl, GeneID, HGNC

Source UniProt

Patents35

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1442880P51589Espacenet
JP 2025147176 A2025-10-063891P51589Espacenet
JP 2025529142 A2025-09-046101P51589Espacenet
US 12371689 B22025-07-296101P51589Espacenet
JP 2025032204 A2025-03-1127022P51589Espacenet
JP 2025028160 A2025-02-283891P51589Espacenet
KR 1020250010750 A2025-01-213891P51589Espacenet
EP 4461818 A22024-11-1327022P51589Espacenet
JP 2024112982 A2024-08-214417P51589Espacenet
JP 2024109657 A2024-08-143898P51589Espacenet

1 to 10 of 35

See all 35 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants819

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleCYP2J2 papersNewest fiscal year
ZIAES025034Characterization And Functional Significance Of P450 Arachidonate Epoxygenases522025
R35ES030443Bioactive lipids as effectors and indicators of the deleterious effects of environmental exposure on chronic diseases92025
ZIAES025043Alterations In Pulmonary Immune Function And Host Resistance In COX Null Mice62025
T32ES007059Advanced Training in Environmental Health Sciences42025
T32HL086350Training Program in Basic and Translational Cardiovascular Science42025
P30CA068485Cancer Center Support Grant32025
P30DK026743UCSF Liver Center32025
P30ES007033University of Washington Interdisciplinary Center for Exposures, Diseases, Genomics & Environment32025
R01HL085844Functional interactions of cardiac ion channels32025
R35GM118145Nanoscale Approaches to Understanding Membrane Protein Function32025

1 to 10 of 819Source NIH's project files

See all 819 nih grants

Papers1,413

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Immunohistochemical and Transcriptomic Assessment of Cytochrome 2J2 in Prostate and Renal Cancer.Cancers (Basel)202642738330PubTator, text miningPubMed
Exploring and validating hub genes associated with atopic dermatitis through weighted gene co-expression network analysis and machine learning.Medicine (Baltimore)202642629711PubTator, text miningPubMed
Pharmacogenomics of Rivaroxaban: Association of CYP3A4, CYP3A5, CYP2J2, ABCB1, and ABCG2 Variants with Bleeding and Thrombotic Outcomes in Real-World Clinical Practice.Pharmaceutics202642514961PubTator, text miningPubMed
Alterations in Epoxyeicosatrienoic Acids Metabolism in Type 2 Diabetes Mellitus and Potential Association with Retinopathy Progression.Curr Med Chem202642487591PubTator, text miningPubMed
New Insights into Genetic Polymorphisms Influencing the Therapeutic Efficacy and Toxicity of Rivaroxaban.J Clin Pharmacol202642394189PubTator, text miningPubMed
PTX3 facilitates tumor cell migration and invasion through the miR-1255b-2-3p/CYP2J2 axis in oral squamous cell carcinoma.Cancer Cell Int202642393690PubTator, text miningPubMed
Cytochrome P450-mediated metabolism of K31, a Ko143-derived ATP-binding cassette subfamily G member 2 inhibitor.Drug Metab Dispos202642285009PubTator, text miningPubMed
Differential effects of lipid composition on the thermal and functional properties of membrane associated CYP2J2.Protein Sci202642249805PubTator, text miningPubMed
Placental CYP450 gene dysregulation by maternal PFAS: a novel mechanism linking prenatal exposure to altered toddler growth.Environ Health202642231393PubTator, text miningPubMed
An integrated computational framework for hazard identification of emerging contaminants: a case study of 6PPD.Environ Int202642225002PubTator, text miningPubMed

1 to 10 of 1,413

See all 1,413 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/1573

GET https://conductscience.org/api/genes/v1/1573/patents?page=2